Journal of International Oncology››2014,Vol. 41››Issue (1): 63-65.doi:10.3760/cma.j.issn.1673-422X.2014.01.020
Previous ArticlesNext Articles
Wang Gengming, Jiang Hao, Chen Zhendong, Xu Hongbo, Zhou Yufu, Zhang Yajun, Sun Qian, Zhou Yan, Zhang Lei
Online:
2014-01-08Published:
2014-01-22Contact:
Wang Gengming E-mail:lansefeidian777@163.comWang Gengming, Jiang Hao, Chen Zhendong, et al. Expression and significance of hOT7T175 in nasopharyngeal carcinoma[J]. Journal of International Oncology, 2014, 41(1): 63-65.
[1] Lee DK, Nguyen T, O′Neill GP, et al. Discovery of a receptor related to the galanin receptors[J]. FEBS Lett, 1999, 446(1):103107. [2] Katagiri F, Nagai K, Kida A, et al. Clinical significance of plasma metastin level in pancreatic cancer patients[J]. Oncol Rep, 2009, 21(3):815819. [3] Jarzabek K, Kozowski L, Milewski R, et al. KiSS1/GPR54 and estrogenrelated gene expression profiles in primary breast cancer[J]. Oncol Lett, 2012, 3(4):930934. [4] Ziegler E, Olbrich T, Emons G, et al. Antiproliferative effects of kisspeptin10 depend on artificial GPR54 (KISS1R) expression levels[J]. Oncol Rep, 2013, 29(2):549554. [5] 李银玲, 高辉, 王鑫, 等. KiSS1、KiSS1受体GPR54及基质金属蛋白酶9与非小细胞肺癌侵袭转移的关系[J]. 现代肿瘤医学, 2011, 19(8):14871490. [6] Bilban M, GhaffariTabrizi N, Hintermann E, et al. Kisspeptin10, a KiSS1/metastinderived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts[J]. J Cell Sci, 2004, 117(Pt 8):13191328. [7] Masui T, Doi R, Mori T, et al. Metastin and its variant forms suppress migration of pancreatic cancer cells[J]. Biochem Biophys Res Commun, 2004, 315(1):8592. [8] Harms JF, Welch DR, Miele ME. KISS1 metastasis suppression and emergent pathways[J]. Clin Exp Metastasis, 2003, 20(1):1118. |
[1] | Guo Zehao, Zhang Junwang.Role of PFDN and its subunits in tumorigenesis and tumor development[J]. Journal of International Oncology, 2024, 51(6): 350-353. |
[2] | Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[3] | Liu Xiaodi, Su Jianfei, Zhang Jingxian, Wei Xueqin, Jia Yingjie.Research progress of myeloid-derived suppressor cells in tumor angiogenesis[J]. Journal of International Oncology, 2024, 51(1): 50-54. |
[4] | Ye Tongtong, Wu Zeyu, Xi Wenyi, Wang Zhiwei, Jiang Xiaochun, Zhao Chenhui.Role of ABRACL in the occurrence and development of malignant tumors[J]. Journal of International Oncology, 2023, 50(9): 544-547. |
[5] | Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462. |
[6] | Zhang Yuan, Bai Zhiyu, Li Qi, Feng Qinmei.Current status of research on exosomes in malignancies[J]. Journal of International Oncology, 2023, 50(8): 484-488. |
[7] | Gu Anqin, Long Jinhua, Jin Feng.Clinical research progress of immunotherapy for nasopharyngeal carcinoma[J]. Journal of International Oncology, 2023, 50(5): 299-303. |
[8] | Liu Yujie, Zhao Zhiqiang, Wang Zicheng.Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer[J]. Journal of International Oncology, 2023, 50(12): 717-722. |
[9] | Deng Lili, Duan Xingyu, Li Baozhong.Advances of anti-HER2 targeted drugs and combined therapeutic regimens for gastric and esophagogastic adenocarcinoma[J]. Journal of International Oncology, 2023, 50(12): 751-757. |
[10] | Li Lixi, Wen Tingyu, Guan Xiuwen, Zhai Jingtong, Ma Fei.Genetic susceptibility genes and clinical features of early-onset breast cancer[J]. Journal of International Oncology, 2022, 49(4): 206-209. |
[11] | Chen Fangming, Cai Yuanyuan, Li Han, Wang Xiaoli, Kan Hongxing, Li Yang, Hao Furong, Wang Mingchen.Prognostic differences of nasopharyngeal carcinoma patients treated with intensity-modulated radiothe-rapy with different T staging of the seventh and eighth edition of the UICC staging system[J]. Journal of International Oncology, 2021, 48(9): 515-522. |
[12] | Yu Jiaojiao, Wang Jun, Wang Likang, Yao Nan.Advances in the amplification of HER2 in metastatic colorectal cancer[J]. Journal of International Oncology, 2021, 48(4): 246-249. |
[13] | Peng Ya, Liu An, Liu Huowang.Inhibitory effect and mechanism of PSD-007 photodynamic therapy on human nasopharyngeal carcinoma transplanted tumors in nude mice[J]. Journal of International Oncology, 2021, 48(3): 136-142. |
[14] | Zhu Lei, Huang Jianbo.Effects of Epstein-Barr virus DNA load and different treatment methods on the therapeutic effect and prognosis of stage Ⅲ nasopharyngeal carcinoma[J]. Journal of International Oncology, 2021, 48(2): 74-79. |
[15] | Luo Wenxiao, Wu Dehua, Cai Longmei.Prognostic values of immune efficacy biomarkers in the treatment of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2021, 48(12): 743-746. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||